A
$ Value
$0
Shares
44,500
Price
$0
Filed
Apr 7
Insider
Name
Balachandran Madhavan
Title
—
CIK
0001555508
Roles
Director
Transaction Details
Transaction Date
2026-04-01
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
44,500
Footnotes
The shares underlying this option vest entirely on April 1, 2027.
Filing Info
Balachandran Madhavan's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-04-01 | REPL | A | $0 |
| 2025-06-11 | QURE | A | $0 |
| 2025-06-11 | QURE | A | $0 |
Other Insiders at REPL (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| SLATTERY JOSEPH P | — | — | 2026-04-01 |
| BAKER BROS. ADVISORS LP | — | — | 2026-04-01 |
| Astley-Sparke Philip | — | — | 2026-04-01 |
| Pucci Paolo | — | — | 2026-04-01 |
| Dhingra Kapil | — | — | 2026-04-01 |
| Weinand Dieter | — | — | 2026-04-01 |
|
Hill Emily Luisa
Chief Financial Officer
|
— | — | 2026-04-01 |
| Oliger Christy J. | — | — | 2026-04-01 |
|
Patel Sushil
Chief Executive Officer
|
— | — | 2026-04-01 |
|
Xynos Konstantinos
Chief Medical Officer
|
— | — | 2026-04-01 |
|
Schwendenman Andrew
Chief Accounting Officer
|
— | — | 2026-04-01 |
| Peeples-Dyer Veleka | — | — | 2026-04-01 |
|
Sarchi Christopher
Chief Commercial Officer
|
— | $52K | 2026-04-02 |